Liposomal Bupivacaine in Bariatric Surgery

Completed · Phase 2

Conditions studied: Bariatric Surgery Analgesia

In brief

The aim of this study is to perform a randomized controlled trial for patients undergoing bariatric surgery, comparing the need for opiates with and without administration of a transversus abdominis plane (TAP) block using the long acting local anesthetic, liposomal bupivacaine (Exparel®). From this study, the investigators will assess whether use of long acting local anesthetic can reduce the need for opiates in the bariatric population.

Key facts

Study ID

NCT03373591

Run by

Montefiore Medical Center

People needed

219

Starts

2018-01-30

Expected to finish

2018-12-31

Last updated by the study team

2019-11-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Obese patients undergoing bariatric surgery (LSG or LRYGB)
• Patients 18 years of age and older
• Surgical treatment between 01/01/2018 and 12/31/2018 over a 1 year period

You may not qualify if…

• Patients under the age of 18 years old
• Patients taking any opiates within 30 days of enrollment in the trial
• Patients with a history of chronic pain.
• Patients taking pregabalin or gabapentin.
• ASA IV
• Prior laparotomy
• Body Mass Index ≥ 60 kg/m2
• History of cardiac arrhythmia
• History of Seizure
• Psychiatric Diagnosis currently on antipsychotic medication

Where it is running

• Montefiore Medical Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.